Cupid Limited Q4 FY26: Record growth, widening margins, and a sharper FMCG push

Cupid Limited closed Q4 FY26 with its strongest quarter on record, capped by a sharp acceleration in full-year performance. On a consolidated basis, total income in Q4 FY26 rose to INR 132.04 crore from INR 61.11 crore in Q4 FY25. EBITDA expanded to INR 37.52 crore, and net profit climbed to INR 36.26 crore. For FY26, total income nearly doubled to INR 391.40 crore, EBITDA rose to INR 116.70 crore, and net profit increased to INR 108.23 crore.

The company positions this outcome as a step-change year, driven by operating leverage and execution across exports, the domestic FMCG rollout, diagnostics, and institutional supply. The presentation also frames FY26 as a year where the company exceeded its own stated guidance, while setting a substantially higher revenue and profitability trajectory for FY27 to FY29.

What drove FY26: exports remained the anchor, FMCG grew into a meaningful leg

Cupid’s business model continues to be defined by a dual engine. The first is the export-led B2B franchise built around institutional procurement programs and global agencies. The second is a fast-expanding branded FMCG platform across personal care and wellness categories in India.

The FY26 revenue mix disclosed in the presentation shows condoms still form the core, but FMCG now carries meaningful weight. Male condoms contributed INR 181.11 crore (51.60%) and female condoms contributed INR 60.72 crore (17.27%). IVD kits and lubricants together contributed INR 24.97 crore (7.11%). New FMCG products contributed INR 84.26 crore (24.01%).

Exports remained the majority contributor, with exports stated at INR 208.13 crore (59.30% of revenue) and presence across more than 125 countries. The deck highlights Africa as a strong base, while also pointing to increasing penetration in regulated markets supported by certifications.

Financial snapshot (consolidated)

The quarter’s profitability profile stands out even within the context of strong growth. In Q4 FY26, EBITDA margin improved to 31.27% and net profit margin to 30.23%. For the full year, EBITDA margin moved to 32.63% and net profit margin to 30.26%. The presentation attributes this to operating leverage and efficient execution.

FMCG distribution: Baazar Style Retail as the core scaling lever

A central strategic message of the deck is that Cupid is using capital allocation to accelerate the domestic FMCG business. The company discloses a strategic investment of INR 331.53 crore in Baazar Style Retail Limited, with INR 82.88 crore deployed in the first phase. It also mentions that 1.01 crore warrants have been allotted, convertible into equity shares.

Operationally, the stated benefit is immediate retail access. Cupid highlights direct access to 260+ stores from day one, with a plan for the network to scale to more than 500 stores over the next two to three years. The company expects this ecosystem to generate about INR 150 crore incremental revenue in FY27 and scale up to about INR 500 crore annually within three years.

Alongside this, Cupid describes a rapid expansion of retail availability for its FMCG products, stating presence across 1.50 lakh+ retail outlets nationally. The deck provides channel-wise counts, including chemists, cosmetics, groceries, and other trade channels. Modern trade listing is cited at 2,934+ stores with 4,000+ projected for FY27. E-commerce is described through order volume, with 52K+ orders serviced.

This is important because it signals that the company is attempting to convert a historically institutional and export-driven manufacturing business into a more balanced B2B and B2C model. If executed well, such a mix can diversify demand, lift brand equity, and potentially support margin resilience. The presentation explicitly frames this dual model as providing stability and margin upside.

Product and capability: premium nitrile female condoms and dual-polymer differentiation

On the manufacturing side, Cupid emphasizes product innovation and process capability as a differentiator. During Q4 FY26, the company states it commenced a development program for nitrile female condoms. It positions nitrile as a premium category that commands 25–35% higher pricing and notes that this segment has historically been supplied by a single global manufacturer.

The deck also states the company has dual polymer manufacturing capability, describing itself as the only condom manufacturer in India able to produce both latex and nitrile condoms on dedicated lines with no cross-contamination. The capacity numbers provided are approximately 1.25 billion male condoms and approximately 125 million female condoms annually.

A branding and quality initiative is also highlighted. The company references a collaboration with one of Asia’s oldest latex condom manufacturers and describes the theme as Made in India with Japanese Quality, aimed at strengthening product quality, technology excellence, and OEM positioning.

Diagnostics: regulatory approvals that widen addressable markets

Cupid’s IVD business remains smaller in the disclosed revenue mix, but the deck makes a clear strategic case for expanding this segment through regulatory approvals. During FY26, the company reports receiving CE EU IVDR certification for HIV 1&2 Antibody and Hepatitis B Surface Antigen test kits, and CE certification for syphilis and pregnancy test kits.

The stated implication is access to the European Economic Area and other CE-recognized markets, and improved eligibility for government tenders, multilateral programs, and public health screening initiatives. The company frames IVD as an emerging growth engine beyond core sexual wellness products.

Balance sheet and liquidity: cash build with low leverage

The consolidated balance sheet presented for FY26 shows total assets of INR 553.22 crore. Cash and bank balance increased to INR 186.45 crore from INR 68.57 crore in FY25. Inventories rose to INR 70.04 crore from INR 41.67 crore, and trade receivables increased to INR 100.79 crore from INR 67.03 crore.

On leverage, the annual performance slide reports a debt-to-equity ratio of 0.11x for FY26 and interest coverage of 39.75x. The company also highlights securing 6+ months of raw material inventory, presented as a buffer against supply disruption and input volatility.

One area that remains difficult to assess from the presentation alone is the sharp movement in Other Current Assets, which is shown at INR 12.08 crore in FY26 versus INR 101.21 crore in FY25. The deck does not provide a note explaining this swing.

Outlook: aggressive scale targets through FY29

Cupid provides explicit forward targets for revenue and net profit through FY29. For FY27, the company targets revenue of INR 600 crore and net profit of INR 180 crore. For FY28, revenue is targeted at INR 875 crore with net profit of INR 275 crore. For FY29, revenue is targeted at INR 1,150 crore with net profit of INR 390 crore.

Management also states confidence in sustaining the growth trajectory, citing export momentum, a favorable currency environment, and a well-secured raw material position. The presentation adds a qualitative target of about 35% expansion in global footprint over the next year, driven by partnerships, deeper market penetration, and global tenders.

Takeaways for investors

FY26 stands out as a high-growth, high-margin year for Cupid, with Q4 FY26 delivering record performance and the full year showing a clear step-up in scale. The most notable strategic shift is the push to build a retail-led FMCG distribution engine through the Baazar Style ecosystem, with specific revenue ambitions attached.

At the same time, the export-led institutional base remains the anchor, supported by global certifications and stated presence across 125+ countries. Product differentiation efforts like nitrile female condoms and regulatory wins in IVD add optionality. The next phase for investors to track is whether the company can convert these initiatives into repeatable, measurable outcomes while managing working-capital intensity as the business scales.